Shanghai Jiao Tong University School of Medicine: Hypertension trials

The registry lists 20 Hypertension studies with Shanghai Jiao Tong University School of Medicine as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 3Phase 4 9No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney DamageRecruitingNCT07876544Phase 4
• Standardized Antihypertensive Treatment ProtocolNot yet recruitingNCT06790927Not applicable
• Transcutaneous Electrical Acupoint Stimulation on Blood PressureNot yet recruitingNCT06537167Not applicable
• Prospective National Multi-center Registry of Obstructive Sleep Apnea Syndrome in Hypertensive Patients in ChinaRecruitingNCT05735444
• Group Education Helps Smoking Cessation and Hypertension ControlNot yet recruitingNCT05530083Not applicable
• Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic HypertensionRecruitingNCT05165251Phase 4
• Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial FibrillationCompletedNCT05528419Phase 4
• The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.Status unknownNCT04931108Phase 4
• Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.Status unknownNCT04929600Phase 4
• Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial FibrillationActive, not recruitingNCT04111419Phase 4
• Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive PatientsCompletedNCT03946514Phase 4
• ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)CompletedNCT03682692Phase 4
• Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan SurgeryCompletedNCT02865733Phase 3
• The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHDCompletedNCT02267200
• Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)CompletedNCT01598441Phase 3
• Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in ChinaCompletedNCT01459042
• Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart DiseaseCompletedNCT01320878Phase 2
• Study of Inhaled Iloprost in Pediatric Pulmonary Hypertension (PH) After SurgeryCompletedNCT01310751Phase 2/3
• Amlodipine Prevents Morning Blood Pressure Surge StudyCompletedNCT01030081Phase 4
• Home Monitoring in the Management of Hypertension and Diabetes MellitusStatus unknownNCT00968786Not applicable